Ovarian cancer and the Ashkenazi Inheritance
Ashkenazi Jewish women have a 10 fold higher risk than the general population of having a mutation in the BRCA1 and BRCA2 gene, which can put them at greater risk of ovarian cancer.
On the evening of Wednesday 19th September over 100 men and women packed Bloomstein Hall in Great Cumberland Place, London for a health awareness lecture organised by Ovarian Cancer Action and the West End communities.
Informative talks were given by Professor Hani Gabra, Director of theOvarian Cancer Action Research Centre at Imperial College, and Professor Alan Ashworth of the Institute of Cancer Research.
There was a lively panel debate, chaired by Professor Stan Kaye, of the Institute of Cancer Research. The panel included geneticist Dr James Mackay, and GP doctor Debbie Kirklin. Allyson Kaye, Chair,Ovarian Cancer Action, who was also a panellist on the evening said "It was good that people came away knowing more about the importance of their family history and the symptoms of ovarian cancer".
The Ashkenazi Inheritance leaflet is available by calling 0208 238 7605, emailing info@ovarian.org.uk